The influence of Synovex-S ® (SYN) ear implant (200 mg progesterone and 20 mg estradiol benzoate) and Somavubove ® (SbV) recombinant bovine growth hormone (.1 mg/kg BW i.m., daily) on live animal performance, tissue growth, and the partitioning of energy gain was determined using a slaughter-balance protocol with 25 young MARC II × (Angus-Hereford crossbred) beef steers (initial BW 182 ± 1.8 kg). Following 21 d of adjustment to individual pens and to a diet of 80% concentrate and 20% corn-grass (1:1) silages, five groups of five steers per group were assigned to initial slaughter or a 2 × 2 factorial arrangement of treatments of CTL (no implant + daily placebo i.m. injection of bicarbonatesaline), SYN (implant + placebo), SbV, or SYN + SbV and slaughtered at 56 d on treatment. Steers were fed (per kilogram BW .75 daily) 20 g of CP and 252 Kcal of ME and consumed 5.5 ± .07 kg/d DM across treatments. Empty body and carcass gains were affected (SYN, P < .01; SbV, P < .01) by treatments (CTL, SYN, SbV, and SYN + SbV: 1.26, 1.43, 1.63, 1.78 kg/d, SEM = .05, and .78, .97, .97, 1.08 kg/d, SEM = .04, respectively). Noncarcass gain was .45, .48, .60, and .60 kg/d (SEM = .03; SbV, P < .01). For empty body, both protein and water gains were greater for SYNimplanted steers ( P < .05) than for steers not implanted and for SbV-injected steers ( P < .01) than for placebo-injected steers. Treatments did not influence the efficiency of energy gain. The proportional amount of energy deposited as protein was greater ( P < .01) for SbV-injected steers than for placebo-injected steers. The proportional amount of protein deposited was not influenced by SYN ( P > .10); however, means were numerically greater for SYN-implanted steers than for steers not implanted, the largest mean being for the SYN + SbV treatment group. Somavubove increased ( P < .01) the efficiency of energy deposited as protein in both the empty body and carcass compared with steers not receiving SbV. Efficiency of energy deposited as protein in the empty body tended to be greater ( P < .10) for SYN-implanted steers than for steers not implanted. The efficiency with which total feed energy was deposited as protein in empty body was 10% greater for the SYN group than for the CTL group, 21% greater for the SbV group than for the CTL group, and 37% greater for the combined SYN + SbV treatment than for the CTL group. The data from this study are interpreted to indicate that SYN and SbV act in an additive manner to improve growth and protein deposition in young growing steers.
Introduction
Estrogenic growth promoters increase the rate of protein deposition in feedlot steers 22 to 25% (Rumsey et al., 1981; Rumsey, 1982) , with variable results between carcass and noncarcass gain. Bovine growth hormone increases gain and protein deposition in feedlot steers, but reports in the literature suggest the greatest effect on steers is in the noncarcass fraction (Early et al., 1990; Moseley et al., 1992; Schwarz et al., 1993 ). An additive effect of estrogen and growth hormone treatment on weight gain of feedlot steers (Preston et al., 1995) and on protein deposition in young dairy steers (Enright et al., 1990 ) has been suggested. Hongerholt et al. (1992) determined that the combination of trenbolone acetate/estradiol-17 beta implant and growth hormone-releasing factor had an additive effect on insulin-like growth factor-I ( IGF-I) and plasma urea nitrogen concentrations in 290-kg steers, suggesting that estrogenic growth promoters may increase BW gain through an influence on IGF-I. Thus, estrogen and growth hormone may have additive effects on tissue protein deposition in young beef steers in that growth hormone may enhance the effect of estrogen implants via the IGF-I axis and estrogens may enhance the growth effect of growth hormone via directing more nutrients toward carcass rather than noncarcass protein deposition.
The objective of this study was to examine the effects of separate and combined treatments of the estrogenic growth promoter Synovex-S ® ( SYN) and recombinant bovine growth hormone (Somavubove ® , SbV) on growth performance, carcass component gain, and composition of gain in young beef steers. A companion paper (Ono et al., 1996) reports results on the morphology and composition of specific muscles from the steers in this study.
Materials and Methods
Animals, Management, and Diet. The study used 25 young beef steers from the fall calf crop of the AngusHerford nutrition cow herd maintained at the Beltsville Agricultural Research Center. Calves were sired by a bull from composite population MARC II (Gregory et al., 1991) with semen obtained from the Roman L. Hruska U.S. Meat Animal Research Center (Clay Center, NE) to help maximize growth rate and frame size for this study. The steers were born over a 4-wk time frame and averaged 7 mo of age. Average initial BW of the steers was 182 ± 1.8 kg.
This study was conducted under the guidelines of an animal protocol approved by the Beltsville Institutional Animal Care and Use Committee. All steers were accustomed for 21 d before the start of the study to individual pens (1.6 m × 9.1 m ) with automatic watering bowls and to the experimental diet. Pens were cleaned daily, and steers were turned into a common exercise lot twice daily.
Steers were fed a freshly mixed total diet once daily at 0900, and any orts were measured daily. All steers were weighed on two consecutive days at the beginning and at the end of the study and weekly during the study. Body weights were obtained at approximately 0800 each weigh day before feeding.
All steers were fed the same diet throughout the study. The diet dry matter consisted of 20% silage and 80% corn-soybean meal concentrate . The silage portion of the diet contained 50% corn silage and 50% orchardgrass silage and the concentrate portion of the diet contained 50% cracked corn, 18% soybean meal (44%), 10% cottonseed hulls, 10% wheat straw, 9% molasses, and 3% salt and mineral mix. The diet dry matter contained 21% crude protein and an estimated (NRC, 1984) 2.65 Mcal of ME/kg. The diet was formulated (NRC, 1984) to provide an excess of CP (20 g CP/kg BW .75 daily) and to provide 252 k cal of ME/kg BW .75 daily, and was fed to achieve 1.2 kg/d BW gain (NRC, 1984) in the control steers. Across treatments, consumption of DM averaged 5.5 ± .07 kg/d for the experiment. Silages were sampled weekly for DM determination. The total mixed diet was sampled daily and composited weekly for analysis of DM, Kjeldahl N, and total energy. On the basis of determinations of DM in the weekly silage samples, diet was adjusted weekly to maintain the 80: 20 ratio of concentrate to silage DM; on the basis of live BW changes, DM intakes were adjusted weekly.
Experimental Design and Treatments. The design was a randomized complete block with the fed steers arranged in a 2 × 2 factorial ( n = 5). The treatments were 1 ) CTL (control, no implant and a daily placebo injection of bicarbonate/saline i.m.), 2 ) SYN (Synovex-S ear implant on d 0 of 200 mg progesterone and 20 mg estradiol benzoate plus a daily placebo injection), 3 ) SbV (no ear implant and a daily injection of the recombinant bovine growth hormone Somavubove at .1 mg/kg BW i.m.), and 4 ) SYN + SbV. The injections were in the neck region just anterior to the shoulders. There were no abscesses observed in the study. Synovex-S was purchased from Syntex Animal Health (West Des Moines, IA), and Somavubove was supplied by The Upjohn Company (Kalamazoo, MI).
Slaughter Balance Protocol. The 25 steers were assigned to five groups of 5 steers each on the basis of BW to equalize BW across groups. The groups were randomly assigned to an initial slaughter group or the four treatment groups. A goal was to initiate treatment at 180 kg live BW. The initial slaughter group (182 ± 1.9 kg) was slaughtered near the beginning of the study to establish initial compositional characteristics. For the treatment groups, the steers were blocked from heaviest to lightest; the heaviest steer from each group of the four treatments as block 1 to the lightest steer from each treatment group as block 5. The blocks were sequentially started on the trial to more closely match the goal of a 180-kg starting weight, to equalize the 56-d feeding period across steers, and to match a sequential slaughter schedule necessary for processing the steers through our abattoir. Starting live BW averaged 182 ± 1.7 kg. The steers were slaughtered within a 3-to 4-wk period after 56 d on trial. All steers were slaughtered at the Beltsville abattoir facility following the second consecutive day of weighing without withdrawal from water and before feeding.
Steers were killed by captive-bolt stunning and exsanguination. Weights of the following components were obtained immediately following slaughter: blood, hide, heart, liver, spleen, kidneys, pituitary, total gastrointestinal tract ( GIT) contents, tissue of individual GIT segments (stomach [rumen, reticulum, Table 1 . Initial live body weight and the effects of an estrogenic growth promoter (Synovex-S ® ) and recombinant bovine growth hormone (Somavubove ® ) on intake and performance of growing beef steers a CTL = no implant and a daily placebo injection of bicarbonate/saline i.m., SYN = Synovex-S ® ear implant on d 0 of 200 mg progresterone and 20 mg estradiol benzoate plus a daily placebo injection, SbV = No ear implant and a daily injection of Somavubove ® at .1 mg/kg BW i.m.
b Statistical results: X = SYN × SbV interaction, NS = significant ( P > .10), † P < .10, **P < .01. All components were weighed fresh and were weighed again after a 48-h chill just before grinding to account for evaporative loss. Organ, blood, and hide components were stored in covered plastic tubs. Organs, blood, and hide were combined with remaining noncarcass components before grinding and sample collection. Samples of noncarcass, stomach, small intestine, large intestine, and carcass tissues were analyzed for moisture (lyophilization), nitrogen (macro Kjeldahl), lipid (ether extract), ash (muffle furnace at 600°C), and energy (adiabatic bomb calorimetry) as described by Rumsey et al. (1981) . Analytical dry matter was used to account for any residual moisture due to sample processing.
Data from the initially slaughtered steers were used as a baseline from which the initial composition of the fed steers was calculated (Rumsey et al., 1981) . Component gains were then calculated based on the difference between final and calculated initial compositions.
Statistical Analysis. Live BW gain was calculated by regression of BW on weeks for the 56-d feeding period, and tissue gain was calculated by dividing total gain by the number of days between the start of the study and the day of slaughter. Data were analyzed by the GLM procedure of SAS (1985) with the model consisting of SYN, SbV, and the SYN × SbV interaction. When a significant interaction occurred ( P < .05), individual means were compared using Duncan's multiple range test. Block was initially considered as a factor in the model, but, presumably because of the initial uniformity of BW and age, block was not a significant factor.
Results
Starting and final live BW, intakes, and the influence of SYN and SbV on performance are summarized in Table 1 . Intake was based on feeding pre-set amounts per unit of BW .75 , adjusted weekly. Thus, the trend ( P < .10) toward greater daily intakes of DM, protein, and energy for steers injected with SbV (2.3%) compared with placebo-injected steers was because of treatment effects on live BW changes during the study. Final BW was greater ( P < .01) for SbV-injected steers than for placebo-injected steers and tended to be greater ( P < .10) for SYN-implanted steers than for steers not implanted. Average daily BW gain and gain/intake were positively affected ( P < .01) by both the SYN and SbV main effects (greater for SbV-injected steers than for placebo-injected steers and greater for SYN-implanted steers than for steers not implanted). Among the four treatment groups, ADG was 16% greater for SYN steers than for CTL steers, 28% greater for SbV steers than for CTL steers, and 40% greater for SYN + SbV steers than for CTL steers. Respective differences relative to CTL steers for gain/intake were 12%, 24%, and 37%. These live steer performance data suggest an additivity of response because the main effects but not the interaction were significant, and the sum of the individual responses (SYN vs CTL and SbV vs CTL) approximated the response to the combined treatment (SYN + SbV vs CTL). A significant interaction would suggest either a synergistic or antagonistic response when SYN and SbV treatments are combined.
Total weight per steer recovered during slaughter averaged 242.6, 253.0, 262.6, and 264.8 kg (SYN, P < .01; SbV, P < .01; SEM = 3.0 kg) for the CTL, SYN, SbV, and SYN + SbV groups, respectively. These Table 2 . The effects of an estrogenic growth promoter (Synovex-S ® ) and recombinant bovine growth hormone (Somavubove ® ) on body component weights at slaughter of young growing beef steers a CTL = no implant and a daily placebo injection of bicarbonate/saline i.m., SYN = Synovex-S ® ear implant on d 0 of 200 mg progesterone and 20 mg estradiol benzoate plus a daily placebo injection, SbV = no ear implant and a daily injection of Somavubove ® at .1 mg/kg BW i.m.
b Statistical results: X = SYN × SbV interaction, NS = not significant ( P > .10), † P < .10, *P < .05, **P < .01. c Gastrointestinal fill is presented as kg/100 kg of total BW. .1, and 96.3% and were not different among treatment groups ( P > .10; SEM = .5%). A major part of the unrecovered weight was probably urine and feces lost during transport and the short holding period between morning weighing at the feeding site and slaughter at the abattoir. A summary of the body component weights of the steers at slaughter for the four treatment groups after 56 d of feeding is shown in Table 2 . Results are summarized to reflect treatment effects on total weight of each component, and, additionally, results are presented as grams per kilogram empty BW to reflect compositional differences between treatments independent of treatment influences on final BW. The SYN × SbV interaction was not significant for any of the body component weights except a trend ( P < .10) for heart weight.
The carcass (SYN, P < .01; SbV, P < .01) and noncarcass (SYN, P < .05; SbV, P < .01) components reflected the influence of treatment additivity observed for BW gain. The differences among treatments for carcass and noncarcass weights seemed to be a function of overall BW differences and did not reflect a shift in the relative weights of these components as a proportion to empty BW. Similarly, this additive effect of treatment tended ( P < .10) to be reflected in the weights of the blood and hide components. As with carcass and noncarcass, the additivity trends observed for blood and hide did not reflect a shift in relative weight as a proportion of empty BW. Within the noncarcass, there were no clearly defined treatment effects on the weight of the gastrointestinal tract or on the stomach, small intestine, or large intestine components, and as a proportion of empty BW, the relative weights of these gastrointestinal components were not clearly affected by SbV treatment. However, the proportional weight of gastrointestinal tissue was less ( P < .05) in SYN-implanted steers than in steers not implanted. This effect on the proportional weight of gastrointestinal tissue was primarily due to a SYN effect on the proportional weight of stomach tissue. Heart ( P < .05), liver ( P < .01), and spleen ( P < .05) were heavier in SbV-injected steers than in placebo-injected steers, and the remainder component tended to be heavier ( P < .10) in SbV-injected steers than in placebo-injected steers. The SbV effect on spleen and remainder components was primarily related to the overall treatment effect on empty BW; their weights as a proportion of empty BW were not different ( P > .10). However, SbV seemed not only to increase heart and liver weight in relation to empty BW, but also to increase heart ( P < .05) and liver weight ( P < .01) as a proportion of empty BW. Among the organs, the proportional weight of the kidney and remainder components were less for the SYN-implanted steers than for steers not implanted, and the proportional weight of liver tended to be lower in SYNimplanted steers than in steers not implanted. As with the BW gain data, these component weight data suggest additivity between the SYN and SbV treatments for both overall carcass and noncarcass weights and suggest some selective effects within the noncarcass component.
Treatment effects on analytical fractions (DM, protein, fat, ash, water, and energy) within the total empty body and its components (carcass, noncarcass, gastrointestinal tract, stomach, small intestine, and large intestine) are summarized for total weight (Table 3 ) and the concentration (Table 4 ) of each analytical fraction. As a reference, total weight of each body component can be derived from the means in Table 2 . There were few treatment interaction effects on the amounts of the analytical fractions. Carcass ash was the only analytical fraction significantly affected ( P < .05) by the SYN × SbV interaction, means indicating a positive but antagonistic effect of treatments. A similar but opposite directional trend ( P < .10) was observed for total noncarcass ash, which was significant ( P < .05) for ash concentration in the noncarcass fraction (Table 4) . Because ash in the empty body fraction was not affected by treatment, these results suggest that treatments caused a proportional shift in ash toward the carcass, particularly for the SYN treatment.
For empty body, effects of treatment (SYN, P < .05; SbV, P < .01) on the amounts of protein and water reflect the positive and additive influences of treatment as seen for performance and BW. The same treatment effects or numerical trends of additivity were seen for protein and water in the carcass and noncarcass components. These differences were not found for dry matter, fat, and energy, primarily because the largest amount of fat was found for steers in the SYN group compared with the other three groups. More ( P < .05) gastrointestinal tract protein and water, more stomach protein ( P < .05), and a trend toward more stomach water ( P < .10) also were observed in SbV-injected steers compared with placebo-injected steers. Additionally, empty body fat and carcass fat were lower in SbV-injected steers than in placebo-injected steers.
We observed a major influence of SbV on the relative analytical composition of the total empty body and of the various body components, expressed as grams per kilogram or as kilocalories per kilogram (Table 4) . For both empty body, carcass, and noncarcass, concentrations of protein ( P < .05) and water ( P < .01) were greater for SbV-injected steers than for placebo-injected steers. Conversely, for empty body, carcass, and noncarcass, concentrations of DM and fat were significantly lower in SbV-injected steers than in placebo-injected steers. Additionally, energy concentration of the large intestine component was lower for SbV-injected steers than for placebo-injected steers and energy concentration of the stomach components and fat concentration of the stomach and large intestine components either tended to be or were numerically lower for SbV-injected steers than for placebo-injected steers.
Empty body component gains of the CTL-, SYN-, SbV-, and SYN + SbV-treated steers are summarized in Table 5 . As with live BW gain, the gains for empty body, carcass, and noncarcass determined from the slaughter weights were greater ( P < .01) for SYNimplanted steers than for steers not implanted and for SbV-injected steers than for placebo-injected steers. There was essentially a complete lack of interaction between the SYN and SbV treatments, except for a trend ( P < .10) for heart gain. To various degrees, blood and hide gains tended to reflect the same treatment effects as for the carcass and noncarcass fractions. Kidney gain was greater ( P < .05) for SbVinjected steers than for placebo-injected steers and tended to be less ( P < .10) for SYN-implanted steers than for steers not implanted. Weight gains of heart, liver, spleen, and the remainder fraction to various degrees were all greater for SbV-injected steers than for placebo-injected steers. In general, weight gains for the carcass and total noncarcass reflected the additive effects of treatment obtained for live BW gain and for final body component weights.
The chemical composition of the gain for empty body, carcass, and total noncarcass is summarized in Table 6 . For empty body, both protein and water gains were greater for SYN-implanted steers ( P < .05) than for steers not implanted and for SbV-injected steers ( P < .01) than for placebo-injected steers. Fat gain for the empty body was less ( P < .05) for SbV-injected steers than for placebo-injected steers; however, the effect of SYN on fat gain was variable, being numerically greater for steers in the SYN group than for steers in the CTL group and least for the steers in the SYN + SbV group. Neither the main effect of SYN nor its 
a CTL = no implant and a daily placebo injection of bicarbonate/saline i.m., SYN = Synovex-S ® ) ear implant on d 0 of 200 mg progesterone and 20 mg estradiol benzoate plus a daily placebo injection, SbV = no ear implant and a daily injection of Somavubove ® at .1 mg/kg BW i.m.
b Statistical results: X = SYN × SbV interaction, NS = not significant ( P > .10), † P < .10, *P < .05, **P < .01. cd Means within a row with different letters in their superscripts differ at P < .05. interaction with SbV was significant ( P > .10). This is consistent with the differences observed for body composition in Tables 3 and 4 . Ash and energy gains for empty body were not influenced by treatment ( P > .10).
For carcass and noncarcass components, the same numerical trends for protein and water gains were obtained as for empty body, although some effects were not significant. The effect of SYN on carcass protein gain was not significant ( P > .10) in this Table 4 . Composition (g/kg DM) and energy (kcal/kg DM) content of steers treated with an estrogenic growth promoter (Synovex-S ® ) and recombinant bovine growth hormone (Somavubove ® ) a CTL = no implant and a daily placebo injection of bicarbonate/saline i.m., SYN = Synovex-S ® ear implant on d 0 of 200 mg progesterone and 20 mg estradiol benzoate plus a daily placebo injection, SbV = no ear implant and a daily injection of Somavubove ® at .1 mg/kg BW i.m.
b Statistical results: X = SYN × SbV interaction, NS = not significant ( P > .10), † P < .10, *P < .05, **P < .01. cd Means within a row with different letters in their superscripts differ at P < .05. b Statistical results: X = SYN × SbV interaction, NS = not significant ( P > .10), † P < .10, *P < .05, **P < .01. b Statistical results: X = SYN × SbV interaction, NS = not significant ( P > .10), † P < .10, *P < .05, **P < .01. cd Means within a row with different letters in their superscipts differ at P < .05. the data show an apparent shift toward greater protein gain, particularly for steers in the SYN + SbV group, with some reduction in fat gain such that energy gain was not affected by treatment ( P > .10). Synovex-S-implanted steers tended toward greater ( P < .10) energy gain in the carcass component compared with steers not implanted.
Concern from previous studies with heavier cattle has been an apparent increase in visceral (including liver) gain with little or no effect on carcass gain in growth hormone-treated steers. The effects of SYN and SbV on the chemical composition of gain in the total gastrointestinal tract, stomach, small intestine, and large intestine components are summarized in Figure 1 . Effects of Synovex-S ® and Somavubove ® on energy efficiency and partitioning into protein and fat in the whole body of young beef steers. Graph a shows that the efficiency of total energy gain for the total empty body (energy gain:ME intake) was similar across treatments (P > .10, SEM = 1.5 [kcal/kcal] × 100). Graph b shows, for total empty body energy gain, that the proportional amount of energy deposited as protein vs fat (protein:fat) was greater for SbV-treated steers (P < .01, SEM = .07). Although not significant (P > .10), the greatest numeric mean was obtained for steers given the combination of SYN + SbV. CTL = no implant and a daily placebo injection of bicarbonate/saline i.m., SYN = Synovex-S ® ear implant on d 0 of 200 mg progesterone and 20 mg estradiol benzoate plus a daily placebo injection., SbV = no ear implant and a daily injection of Somavubove ® at .1 mg/kg BW i.m. Table 7 . The effects of SYN and SbV on chemical gains of the gastrointestinal tract were minimal. Injecting steers with SbV increased ( P < .05) the protein and water gains for the total gastrointestinal tract and increased protein ( P < .05) and water ( P < .10) gains for the stomach component compared with placeboinjected steers. No other treatment effects were apparent. Thus, the general increase in empty BW and numerical increase in gastrointestinal weight in SbV-injected steers compared with placebo-injected steers was accompanied by a selective increase in protein tissue in the gastrointestinal tract.
The influences of SYN and SbV on gain efficiency and partitioning of feed energy into protein and fat tissue are summarized in Figures 1 and 2. Figure 1 b shows the efficiency of total energy gain, and Figure  1b shows the proportional amount of energy deposited as protein vs fat for the total empty body. Treatment did not influence the efficiency of energy gain. The proportional amount of energy deposited as protein was greater ( P < .01) for SbV-injected steers than for placebo-injected steers. The proportional amount of protein deposited was not influenced by SYN ( P > .10). However, means were numerically greater for SYN-implanted steers than for steers not implanted, the largest mean being for the SYN + SbV treatment group. The ratio of protein gain to fat gain for the total empty body was 8% greater for the SYN steers than for the CTL steers, 43% greater for the SbV steers than for the CTL steers, and 71% greater for the SYN + SbV steers than for the CTL steers. Figure 2 a shows the efficiency of protein energy gain for the total empty body and Figure 2b shows the efficiency of protein energy gain for the carcass. As with the protein:fat ratio (Figure 1b) , efficiency of total feed energy deposited as protein in both the total empty body and carcass was greater ( P < .01) in SbVinjected steers than in placebo-injected steers. There was a trend ( P < .10) for the efficiency of total feed energy deposited as protein in the empty body to be greater for SYN-implanted steers than for steers not implanted, and this effect approached significance for the carcass ( P < .15). The efficiency with which total feed energy was deposited as protein in the empty body was 10% greater for steers in the SYN group than for steers in the CTL group, 21% greater for steers in the SbV group than for steers in the CTL group, and 37% greater for steers in the SYN + SbV group than for steers in the CTL group. Respective increases for the carcass component were 4%, 13%, and 29%.
Discussion
Synovex-S in the present study increased live BW gain by 16% and protein deposition by 11%. The stimulation of live BW gain was typical of that Figure 2 . Effects of Synovex-S ® and Somavubove ® on energy efficiency of protein gain in young beef steers. Graph a shows that efficiency of protein energy gain for the total empty body (protein gain:ME intake, SEM = .58 [kcal/kcal] × 100) was greater for SbV-treated steers (P < .01) and tended to be greater for SYN-treated steers (P < .07). Results suggest an additive effect of SYN and SbV. Graph b shows that efficiency of protein energy gain for the carcass (protein gain:ME intake, SEM = .40 [kcal/ kcal] × 100) was greater for SbV-treated steers (P < .01) and, although not significant for SYN, approached significance at P < .15. Numerical values suggested a trend for an additive effect of SYN and SbV. CTL = no implant and a daily placebo injection of bicarbonate/ saline i.m., SYN = Synovex-S ® ear implant on d 0 of 200 mg progesterone and 20 mg estradiol benzoate plus a daily placebo injection., SbV = no ear implant and a daily injection of Somavubove ® at .1 mg/kg BW i.m.
observed with estrogenic growth promoters, but it is not clear why fat deposition was numerically increased by SYN in this study whereas protein deposition response in this study was only half that noted in previous studies with estrogen growth promoters (Rumsey et al., 1981; Rumsey, 1982) . One difference between this study and reported comparative slaughter studies (Rumsey et al., 1981; Rumsey, 1982) is that these calves were physiologically younger. Young steers ( 7 mo of age, 182 average BW) from the Beltsville nutrition herd dams and sired by a MARC-II bull from the Roman L. Hruska Meat Animal Research Center (Clay Center, NE) were used to optimize protein deposition over fat deposition.
In our laboratory, a slaughter balance protocol demonstrated that diethylstilbestrol in steers averaging 330 kg BW and fed to gain 1.0 kg/d of live BW improved BW gain by 17% and the rate of protein deposition by 28%, with a slight reduction in the rate of fat deposition (Rumsey et al., 1981) . Protein deposition was increased by diethylstilbestrol 35% in the carcass and 19% in the noncarcass. Under ad libitum feeding conditions, steers averaging 390 kg BW and treated with SYN increased BW gain by 23% and feed intake by 10%. The rate of protein deposition was increased by 25% and the rate of fat deposition was increased by 23% (Rumsey, 1982) . Protein deposition was increased by SYN 25% in the carcass and 11% in the noncarcass. These studies suggest that the effect of estrogenic growth promoters is greatest in the carcass component. Conversely, in the present study with young steers, protein gain was 10% greater for SYN steers in the carcass component and 15% greater in the noncarcass component. If the influence of estrogenic growth promoters is not tissue-specific for protein accretion, then this reversal in carcass vs noncarcass response could reflect a difference in tissue growth priorities between the younger steers in the current study and the older steers in previous studies.
Preston (1975) hypothesized that the growth response to estrogenic growth promoters is through increased somatotropin secretion. A study reported by Rumsey and Elsasser (1989) indicated that the growth response obtained with SYN is associated with an increase in circulating and tissue IGF-I concentrations. Recently Preston et al. (1995) reported that SYN increased plasma concentrations of both somatotropin and IGF-I in feedlot steers, and Rumsey et al. (1996 Rumsey et al. ( , 1997 reported SYN increased growth hormone and thyroid-stimulating hormone release from and 5′-monodeiodinase activity in the pituitary. Elsasser et al. (1992) have reported a positive relationship between BW gain and plasma IGF-I concentration in growing ruminants. Thus, a possible explanation for the effect of estrogenic growth promoters may be a mechanism that works via effects on hypothalamic hormones. One possible hypothesis is that estrogenic growth promoters work through an effect on the hypothalamic axis, resulting in increased release of growth hormone. However, this may be only part of the growth-promoting mechanism of estrogens because we have also demonstrated an influence on TSH release (Rumsey et al., , 1997 and subsequent effects on thyroid status. This effect on the thyroid remains to be further defined in relation to growth responses. Bovine growth hormone has been shown to increase BW gain in cattle (Moseley et al., 1992) . Schwarz et al. (1993) reported that growth hormone increased BW gain by 10%, increased the proportion of lean, and decreased the proportion of fat in beef heifers averaging 400 kg BW. This same effect of growth hormone on the proportions of lean and fat were also demonstrated in the current study. However, final carcass weight was increased by only 1.3%, whereas final total BW was increased by 6.1%. Moseley et al. (1992) reported that for beef steers averaging 450 kg, growth hormone increased BW gain approximately 9% with a shift toward lower fat and higher protein deposition, with no increase in final carcass weight. Early et al. (1990) showed with beef steers averaging 310 kg BW that growth hormone increased BW gain by 15% and increased the lean:fat ratio, but increased carcass weight by only 2%. Ovine growth hormone was found to increase BW gain in lambs by 19% and increase the lean:fat tissue gain, but it did not change carcass weight (Beermann et al., 1990) . Although fat deposition is reduced in growth hormone-treated ruminants, apparently the primary effect on increasing growth rate in studies reported thus far occurred in the noncarcass component. Thus, the combined effects of bovine growth hormone and estrogen treatment on growing beef steers may be additive in nature, particularly in the carcass component. This possibility, however, has not been previously investigated using a slaughter-balance protocol in steers.
In the current study, an additive effect as indicated by significant SYN and SbV effects and the absence of an interaction was suggested for live BW gain, empty body gain, carcass gain, noncarcass gain, empty body protein gain, carcass protein gain, and protein gain per unit of energy intake for both empty body and carcass. This supports the conclusions of Preston et al. (1995) that SYN and somatotropin are additive in their effect on weight gain in 379-kg beef feedlot steers and the conclusions of Enright et al. (1990) who reported for beef steers averaging 340 kg BW an additive effect on BW gain between pituitary-derived bovine growth hormone and estradiol. However, in the latter study, this additive effect was not seen in the same steers at a heavier weight, nor was an additive effect apparent for carcass weight, although an additive effect on plasma IGF-I concentrations was demonstrated. Hongerholt et al. (1992) reported on the metabolite profiles of growing Hereford steers and suggested an additive effect between growth hormonereleasing factor analogue and an estradiol-trenbolone acetate implant. However, Muir et al. (1983) suggested that in sheep, the modes of action of growth hormone and estrogens are different and are primarily related to reduced fat deposition and increased protein deposition, respectively. However, in the young steers in the present study, greater protein gain accompanied a lower fat gain in SbV-injected steers compared with placebo-injected steers. More work is needed to determine mechanistically how these growth-promoting hormones act collectively to promote protein deposition in cattle.
Efficiency of feed energy use for growth was not affected in this study, even though large shifts in the ratio of protein to fat deposited were obtained with the treatments. This is consistent with earlier studies using slaughter balance protocols and treating with diethylstilbestrol (Rumsey et al., 1981) and with Synovex-S (Rumsey, 1982) that demonstrated no effect on efficiency of feed energy use. At the present time it is not obvious how a shift from the deposition of an energy-dense fat tissue to a less-energy-dense protein tissue is coordinated to maintain overall energy efficiency.
Implications
The estrogenic growth promoter Synovex-S ® and recombinant bovine growth hormone (Somavubove ® ) independently increased growth and protein deposition in young beef steers. The combined treatments consistently demonstrated an additive effect on growth rate, carcass growth, protein deposition, and the energy efficiency of protein deposition. From the current study, it would seem that the use of an estrogenic growth promoter with growth hormone may further enhance the effectiveness of the estrogen and may shift the effect of growth hormone toward the carcass components in steers.
